Stroke Management: A 30-Year Retrospective
Looking back on 30 years of successes, such as the game-changing approval of tissue plasminogen activator (tPA), as well as failures in stroke research and treatment.
United States Louis Caplan Beth Israel Deaconess Medical Center Drug Administration National Institute Of Neurological Disease Harvard Medical School
Source: medscape.com